NeoImmuneTech, Inc. Logo

NeoImmuneTech, Inc.

Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.

950220 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
2400 Research Boulevard, Suite 250, Rockville, MD 20850, Rockville
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NeoImmuneTech, Inc. is a clinical-stage, T cell-focused biotechnology company dedicated to developing novel immuno-therapeutics. Founded in 2014, the company's core technology is NT-I7 (efineptakin alfa), a long-acting human interleukin-7 designed to amplify the quantity and enhance the functionality of T cells. This proprietary asset is being developed to treat various cancers and infectious diseases. NeoImmuneTech's research and development efforts focus on exploring NT-I7 as both a monotherapy and in combination with other treatments, aiming to expand the horizons of immuno-oncology and address unmet medical needs.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NeoImmuneTech, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-09-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 94.2 KB
2025-09-16 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (주주배정 후 실권주 일반공모)
Korean 7.8 KB
2025-09-16 00:00
Share Issue/Capital Change
증권발행실적보고서
Korean 90.0 KB

Automate Your Workflow. Get a real-time feed of all NeoImmuneTech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NeoImmuneTech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
GC CELL CORPORATION Logo
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
South Korea 144510
GemVax & KAEL Co.,Ltd. Logo
Makes contamination controls for semiconductors & develops Alzheimer's therapeutics.
South Korea 082270
Gencurix Inc. Logo
Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.
South Korea 229000
GENEMATRIX INC. Logo
Develops multiplex PCR diagnostics and new drugs for infectious diseases like HPV and tuberculosis.
South Korea 109820
GeneOne Life Science, Inc. Logo
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
South Korea 011000
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.